Coronavirus news

Spain gets green light to test homegrown COVID vaccine on humans, PM says

Clinical trials for the COVID-19 vaccine developed by Spanish company Hipra

Spain's medicines agency has authorized the first round of clinical trials.

Spain's medicines agency has authorized the first round of clinical trials. | Nacho Gallego

ReutersMadrid11/08/2021 14:10
TW
1

Spain's medicines agency has authorized the first round of clinical trials for the COVID-19 vaccine developed by Spanish company Hipra, Prime Minister Pedro Sanchez said on Wednesday.

The early stage clinical trial will recruit dozens of participants from Spanish hospitals to test the drug's safety and tolerability, as well as its immunogenicity and efficacy, the medicines agency said in a statement.

Hipra, which has manufacturing bases in Spain and Brazil, said it could produce up to 400 million doses in 2022 and 1.2 billion in 2023.

Related news
Restaurant in Mallorca during the pandemic

Pandemic compensation claims by Mallorcan companies rejected by Spain's Supreme Court

More related news

"Spain's medicines and health products agency has just authorized clinical tests of the Spanish COVID vaccine on humans," Sanchez told a news conference in Lanzarote in the Canary Islands.

Hipra, a pharmaceutical lab that mainly researches and manufactures veterinary vaccines, has been working on two COVID-19 shots.

One is based on the same RNA messenger technology used in Pfizer and Moderna's shots, while the second, which has just received approval for trial, uses a recombinant protein like U.S. based drugmaker Novavax.

Also in News

Talking to tourists.

Mallorca holiday paradise vanishing for some German tourists

Cala Torta in Arta, Mallorca

Government buys back Mallorca estates from Kuwait

La Macarena bullring in Felanitx, Mallorca

Abandoned since 2008, a Mallorca bullring has new owners

Passengers at Palma Son Sant Joan Airport in Mallorca

Mallorca hoteliers president: Tourism is being used as "a punchbag"

Most viewed
Most Commented